TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,241,538 | -7.1% | 1,009,702 | +42.3% | 0.05% | +16.3% |
Q2 2023 | $2,412,980 | -14.8% | 709,700 | 0.0% | 0.04% | 0.0% |
Q1 2023 | $2,831,703 | -26.7% | 709,700 | 0.0% | 0.04% | -8.5% |
Q4 2022 | $3,860,768 | +8.1% | 709,700 | 0.0% | 0.05% | +9.3% |
Q3 2022 | $3,570,000 | +32.0% | 709,700 | 0.0% | 0.04% | +38.7% |
Q2 2022 | $2,704,000 | -55.9% | 709,700 | -18.2% | 0.03% | -53.0% |
Q1 2022 | $6,133,000 | – | 867,500 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 3,609,346 | $14,401,291 | 5.31% |
Kohlberg Kravis Roberts & Co. L.P. | 22,675,980 | $90,477,160 | 2.72% |
Worth Venture Partners, LLC | 884,802 | $3,530,360 | 1.72% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,084 | $1,009,805 | 1.18% |
Black Maple Capital Management LP | 43,161 | $172,212 | 0.16% |
Polar Asset Management Partners Inc. | 709,700 | $2,831,703 | 0.04% |
Soros Fund Management | 639,820 | $2,552,882 | 0.04% |
AMERIPRISE FINANCIAL INC | 3,929,048 | $15,676,901 | 0.01% |
Stratos Wealth Partners, LTD. | 25,640 | $102,304 | 0.00% |
FMR LLC | 1,584 | $6,320 | 0.00% |